Facebook Linkedin Twitter
Inside Precision Medicine Enhertu Becomes First Tumor Agnostic HER2-Targeted Treatment Approved

Ovarian cancer

Enhertu Becomes First Tumor Agnostic HER2-Targeted Treatment Approved
News & Features

Enhertu Becomes First Tumor Agnostic HER2-Targeted Treatment Approved

0
Sarcoma cells
News & Features

Next-Generation T Cell Therapy Shows Promise For Solid Tumors

Laura Cowen
0
Cancer cells
News & Features

New Frontiers in Liquid Biopsy

Chris Anderson
0
AI and ovarian cancer
Molecular Dx

Urine-Based Ovarian Cancer Test Shows Promise

0
AI and ovarian cancer
News & Features

Diagnosing the “Silent Killer”: AI Tackles Early Stage Ovarian Cancer

Fay Lin, PhD
0
Scientist holding a DNA sample with the results on a computer screen in a laboratory
News & Features

WGS Plus Health Data Drives Tailored Cancer Care, Large U.K. Study Shows

0
Ovarian Cancer
News & Features

Smear Test Flags Ovarian Cancer

0
Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells
News & Features

AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors

0
Woman cancer patient
News & Features

Institute for Systems Biology and NED Biosystems Will Collaborate to Reverse Cancer Onset

0
3D rendered Illustration of T-Cells of the immune System attacking growing Cancer cells. Gamma delta T cells engineered to attack solid tumors
News & Features

Newly-Engineered T Cells Show “Off-the-Shelf” Potential for Advanced Cancers

0
123...11Page 2 of 11

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine